Money raised at a premium which is good but it does seem to suggest that they are going to self-fund the trials on their own.
Lepu owning 13% would not help a big pharma unless they can get them on side and at a substantial premium to $0.82.
Ann: $29.6m Equity Placement to Lepu Medical Group of China, page-4
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)